Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential cation channel subfamily C member 3 (TRPC3) is a receptor-activated, non-selective cation channel highly permeable to calcium and other cations[5][6][8]. It is part of the canonical TRP (TRPC) channel family and is activated by second messengers such as diacylglycerol, often following stimulation of receptor tyrosine kinases or G protein-coupled receptors[5][6]. TRPC3 regulates intracellular calcium levels and contributes to processes such as neuronal excitability, cell proliferation, vascular tone regulation, and cardiac rhythmicity[5][6][3]. Genetic mutations in TRPC3 are linked to neurodegenerative disorders, including spinocerebellar ataxia 41, and alterations in its function are implicated in memory loss, cardiac arrhythmias, and hypertension[7][6]. Structurally, TRPC3 forms a tetramer with distinct cytoplasmic and transmembrane domains, exhibiting a unique fold within the TRP channel superfamily[4][1][3]. Its pharmacological modulation is under investigation as a therapeutic strategy for cardiovascular and neurological disorders[2][4][7].
Inhibition of channel gating via allosteric interaction (BTDM wedges between domains to inhibit opening) - Activation via lipid second messengers (e.g. diacylglycerol, OAG) - Modulation through phosphatidylinositol pathways and receptor tyrosine kinase or G-protein coupled receptor signaling
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential cation channel subfamily C member 3 (TRPC3).